drugset / Trial / NCT03936517
Safety and Efficacy of Prednisolone in Adrenal Insufficiency Disease (PRED-AID Study)
Phase 3
Unknown
44 enrolled
Imperial College London
Imperial Health Charity · collabNational Institute for Health Research, United Kingdom · collab
RandomizedCrossoverQuadruple-blindTreatment
Summary
This study compares low-dose prednisolone therapy against standard regimens of hydrocortisone therapy for the treatment of adrenal insufficiency (AI). AI is a condition in which, individuals are unable to sufficiently produce the natural stress hormone, cortisol.
Timeline
- Start
- 2019-07-31
- Primary completion
- 2025-02-01
- Completion
- 2025-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydrocortisone | Other / unclassified | — | — |
| Subject | Prednisolone | Other / unclassified | — | — |